series-a
Stage
1
Investors
About
Metacrine develops novel therapies targeting metabolic and liver diseases by modulating bile acid pathways and related metabolic processes.
Explore Metacrine's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.